Ceragon Extends Credit Facility to 2028, Relaxes Covenants, and Discloses New Litigation
CRNT sits 18% above its 52-week low of $1.85.
Summary
Ceragon extended its credit facility to 2028 with relaxed covenants and disclosed a probable $1.16M class action settlement plus two new lawsuits totaling ~$1.56M.
Key Events · Legal and Risk Events · CRNT
-
Credit Facility Extended to 2028
Term extended by 26 months to August 31, 2028. Bank guarantee lines cut by $20.9M to $20.0M, with a new $20.0M uncommitted line approved.
-
Covenants Relaxed
Net debt-to-receivables and net debt-to-working-capital ratios increased from 30% to 50%, giving the company more financial flexibility but indicating lender concessions.
-
Class Action Settlement Estimate
Probable loss under the pending class action settlement estimated at $1,162 thousand; deadline for finalizing settlement extended to September 1, 2026.
-
New Litigation Disclosed
Ceragon Peru sued for ~$560K by a subcontractor; Ceragon Brazil sued for ~$1M by a customer alleging breach of contract.
Analysis · CRNT · Manufacturing
Ceragon amended its revolving credit facility, extending the term to August 31, 2028, while reducing bank guarantee lines by $20.9 million and adding a $20 million uncommitted line. The amendment also relaxes financial covenants, raising the net debt-to-receivables and net debt-to-working-capital ratios from 30% to 50%. This provides more headroom but signals lenders demanded looser terms. Separately, the company disclosed a probable $1.16 million class action settlement loss and two new lawsuits in Peru and Brazil totaling about $1.56 million. These legal items are modest relative to the company's size but add to an already complex risk profile.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 29.6% of the 1609 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRNT was trading at $2.18 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $200.9M. The 52-week trading range was $1.85 to $3.29. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.